Search clinical trials for: Cell Harvest

Total 49554 results

Alexion Pharmaceuticals

Completed

Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Hemoglobinuria, Paroxysmal

United States, Australia, Belgium, Canada, Germany, Italy, United Kingdom, France, Ireland, Netherlands, Sweden, Switzerland
Johann Wolfgang Goethe University Hospital

Terminated

Cell Therapy for Coronary Heart Disease

Coronary Artery Disease

Germany
University of Turin, Italy

Completed

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Multiple Myeloma

Italy
UMC Utrecht
Dutch Health Care Insurance Board

Completed

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

Rheumatoid Arthritis | Polymyositis | Giant Cell Arteritis | Polymyalgia Rheumatica | Wegener's Granulomatosis

Netherlands
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Completed

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

Refractory Solid Tumors

Mexico
Xcyte Therapies

Completed

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Chronic Lymphocytic Leukemia

United States
National Institute of Cancerología

Unknown

DHPLC Determination of TPMT Polymorphisms.

Acute Lymphoblastic Leukemia

Mexico
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

CD133+ Autologous Cells After Myocardial Infarction

Acute Myocardial Infarction

Italy
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Multiple Myeloma | Cutaneous Lymphoma

Australia
Brazilan Center for Studies in Dermatology

Completed

Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring

Cellulite | Body Contouring
International Vaccine Institute
Göteborg University; National Institute of Hygiene and Epidemiology, Vietnam

Completed

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Cholera

Vietnam
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Neoplasms | Multiple Myeloma | Lymphoma, Malignant | Thrombocytopenia

United States, Argentina, Mexico
Pfizer

Completed

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Lung Neoplasms

United States, Canada, Ireland, United Kingdom, Italy, Germany, Spain, Netherlands
Morton Plant Mease Health Care
Ortho Biotech Products, L.P.

Terminated

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Prostate Cancer

United States
Pfizer

Completed

PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients

Carcinoma, Non-Small Cell Lung

United States, Canada
Xcyte Therapies

Unknown

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Multiple Myeloma

United States
Charite University, Berlin, Germany
Bristol-Myers Squibb; Pierre Fabre Pharma GmbH

Unknown

Study for Patients With Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Germany
University of Ottawa
Canadian Institutes of Health Research (CIHR)

Unknown

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

Myocardial Infarction

Canada
Tel-Aviv Sourasky Medical Center
Radiation Therapy Oncology Group

Unknown

URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol

Glioblastoma

Israel
Trial Form Support S.L.
Merck KGaA, Darmstadt, Germany

Unknown

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

Oropharyngeal Neoplasms

Spain
TheraVitae Ltd.
Mahidol University

Unknown

EPC by Intracoronary Injection in Patients With Chronic Stable Angina

Coronary Artery Disease

Israel
Braintree Laboratories

Completed

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Colonoscopy

United States
Charles University, Czech Republic

Unknown

Intracoronary Stem Cells in Large Myocardial Infarction

Myocardial Infarction
Medical University of Vienna

Unknown

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

Austria
Royal Marsden NHS Foundation Trust

Completed

A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

Acute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome
University of Connecticut
Janssen Pharmaceutica N.V., Belgium

Terminated

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

Aggression | Psychosis

United States
GammaCan

Unknown

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Malignant Melanoma | Urologic Cancer | Cancer of Colon

Israel
Hospital Clinic of Barcelona

Terminated

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

HIV Infection

Spain
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
University of Magdeburg

Unknown

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Lymphoma, High-Grade

Germany
University of Magdeburg

Unknown

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Non-Hodgkin's Lymphoma

Germany
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Epithelial Ovarian Carcinoma | Figo Stage IIIC

France
Bayside Health

Unknown

The Role of Naive T-Cells in HIV Pathogenesis

HIV Infections

Australia
Nordic Myeloma Study Group

Unknown

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

Multiple Myeloma

Denmark
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Unknown

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer

Germany
The Alvin and Lois Lapidus Cancer Institute
Ortho Biotech Products, L.P.

Unknown

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Lymphoma, Non-Hodgkin | Diffuse Large B Cell Lymphoma

United States
Korean Multiple Myeloma Working Party
Janssen-Cilag Ltd.

Unknown

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

Multiple Myeloma

Korea, Republic of
University of Bologna

Completed

Autologous Transplantation for Multiple Myeloma

Multiple Myeloma
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Sanofi

Completed

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Colorectal Neoplasms | Colorectal Carcinoma | Metastases
Hamilton Health Sciences Corporation
Eli Lilly and Company

Completed

Olanzapine in the Treatment of Hair Pulling (Trichotillomania)

Trichotillomania

Canada
University of Michigan Rogel Cancer Center
University of Michigan

Terminated

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Metastatic Colorectal Cancer

United States
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Terminated

Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL

Burkitt Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

LMBA02 Protocol for Patients With a Burkitt Lymphoma

Burkitt Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course

- Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy)

France
Lymphoma Study Association

Completed

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma

B-Cell Lymphoma

France, Belgium, Switzerland
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Neoplasms, Connective and Soft Tissue | Osteosarcomas | Medulloblastomas | Rhabdomyosarcomas | Ewing Tumor | Neuroblastomas

France
Memorial Sloan Kettering Cancer Center

Completed

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Hematologic Malignancies | Streptococcal Sepsis

United States
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors

Germ Cell Tumor

France
Heidelberg University
Merck KGaA, Darmstadt, Germany

Unknown

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Glioblastoma Multiforme

Germany

Search clinical trials for: Cell Harvest

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations